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Abstract: This is the first report on a systematic method for constructing a large scale kinetic metabolic model and 
its initial application to the modeling of central metabolism of Methylobacterium extorquens AM1, a 
methylotrophic and environmental important bacterium. Its central metabolic network includes formaldehyde 
metabolism, serine cycle, citric acid cycle, pentose phosphate pathway, gluconeogensis, PHB synthesis and 
acetyl-CoA conversion pathway, respiration and energy metabolism. Through a systematic and consistent procedure 
of finding a set of parameters in the physiological range we overcome an outstanding difficulty in large scale kinetic 
modeling: the requirement for a massive number of enzymatic reaction parameters. We are able to construct the 
kinetic model based on general biological considerations and incomplete experimental kinetic parameters. Our 
method consists of the following major steps: 1) using a generic enzymatic rate equation to reduce the number of 
enzymatic parameters to a minimum set while still preserving their characteristics; 2) using a set of steady state 
fluxes and metabolite concentrations in the physiological range as the expected output steady state fluxes and 
metabolite concentrations for the kinetic model to restrict the parametric space of enzymatic reactions; 3) choosing 
enzyme constants K’s and K’eqs optimized for reactions under physiological concentrations, if their experimental 
values are unknown; 4) for models which do not cover the entire metabolic network of the organisms, designing a 
dynamical exchange for the coupling between the metabolism represented in the model and the rest not included. 
The success of our approach with incompletely input information is guaranteed by two known principles in biology, 
the robustness of the system and the cooperation among its various parts.      
(For reference, the published version can be found as,  Towards Kinetic Modeling of Global Metabolic Networks: 
Methylobacterium  extorquens AM1 Growth as Validation,  P Ao, LW Lee, ME. Lidstrom, Lan Yin, and XM Zhu, 
Chinese Journal of Biotechnology 24 (2008) 980−994.    
  http://journals.im.ac.cn/cjbcn/ch/reader/view_abstract.aspx?file_no=gc08060980&flag=1  
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Introduction 
 
In the post genomic era, many of our current global 
concerns, such as health, energy, and environment, 
need perspectives from bioengineering. In response 
integrated and large scale wet and dry lab approaches 
associated with systems biology have been developing 
rapidly[1–3]. Microbiology has played and will continue 
to play an important role, because bacteria have several 
billion years of experience in exploring various living 
conditions. This approach may give us better ways to 
produce important medical agents, to increase the 
efficiency of using carbon sources, and to turn harmful 
materials into environmentally friendly ones. A key 
component in such endeavors is the mathematical 
modeling of large biological systems. Among them is 
metabolic modeling whose goal is to create a 
comprehensive multidimensional representation of all of 
the biosynthetic reactions in an organism. For this, we 
require mathematical models[4] to perform two ma jor 
functions. First, they should be able to reliably describe 
experimental observations[5], for instance, the models 
  
should indicate the metabolic fluxes and concentration 
of metabolites in each organelle or cell type at a given 
moment under specified conditions. Secondly, it is 
capable of generating experimentally[6,7] testable 
hypotheses leading to new experiments and new results 
which can then be used to refine the model. In the 
process of constructing such a model, new insights may 
often be gained as well. Modeling from the metabolic 
perspectives has been presented in many recent 
excellent reviews[8]. Metabolic networks have been 
discussed parallel to signaling networks[9], and the 
effect of noise in metabolic networks have also been 
discussed from various perspectives[10,11]. 
A survey of the literature suggests that models for 
metabolic networks are primarily (i) stoichiometric 
models[12] which display—in many cases on a genome- 
wide level—an organism’s metabolic capabilities and 
(ii) kinetic models[13–15], which describe at the 
enzymatic level, the rate at which reactions proceed. 
Flux Balance Analysis (FBA)[16], in which mass 
conservation and other constraints are imposed on the 
metabolic network to determine a feasible solution 
space, is often used to evaluate the stoichiometric 
models. These constraints can be, for example, 
thermodynamic[17] and transcription regulatory[18]. 
Stoichiometric models can also be characterized by 
network-based pathway definitions[19]. While useful, 
important temporal behaviors are beyond the reach of 
FBA, such as the transient accumulation of toxic 
intermediate metabolites and the dynamical deficiency 
of an important nutrient. These time-dependent 
behaviors can drastically affect the life process of an 
organism. Nevertheless, kinetic models have not been 
studied as extensively as they should be. The common 
reasons are: a mechanistic formulation of even single 
enzyme kinetics is complicated with many parameters[20] 
and the experimental data for such parameters are 
scarce[7]. However, they are important for modeling 
behaviors such as oscillations[21,22] or bi-stability[23,24] 
that often occur in biological networks. Realistic 
kinetic modeling of large metabolic networks has been 
difficult. A major challenge is how to achieve 
biologically meaningful predictions from the 
mathematical model in the face of sparse experimental 
kinetic parameters and other necessary inputs. 
In this paper, we present a systematic methodology 
to solve this important parameter issue. The first 
problem to be addressed is how to effectively and 
accurately represent an enzymatic reaction which may 
easily contain tens or more molecular parameters. Our 
solution is based on an observation that a complicated 
and exact (in the quasi-steady state sense) enzymatic 
rate equation can be rigorously cast into a generic form 
with the smallest set of kinetic parameters, which have 
transparent biochemical interpretations and can be 
directly related to experimental values. 
The second problem to be addressed is that given the 
set of reactions how can a plausible set of fluxes be 
identified. We have at least two ways to solve this 
problem. One is to use a method related to flux balance 
analysis. Another is to set up a robust kinetic model 
which can generate various fluxes, although the kinetic 
parameters used may not be related to a realistic 
situation. The reason that realistic steady state fluxes 
can be obtained by crude kinetic models is that such 
fluxes are not sensitive to most kinetic parameters. 
The third problem is how to obtain a consistent set 
of all parameters needed with given fluxes. Our 
solution is based on two considerations: to make use of 
as much available experimental data as we can, and to 
use a matching rule. Once a reasonable set of 
parameters is obtained, various predictions can be 
made, and, can be discussed in the biological contexts. 
In addition, various mathematical analyses can be 
carried to further test the consistency of parameters. 
In order to make sure this scheme stays on the right 
track, we have been interacting closely with an 
on-going experimental study:  We have been using the 
Methylobacterium extorquens AM1[25] as our model 
organism for validation and for inspiration. This 
bacterium is well studied as a facultative 
methylotroph[26], meaning it is able to utilize both 
single and multiple carbon unit compounds. A genome 
sequence[27] is available and a global analysis 
integrating data from the metabolome[28–30], 
transcriptome[31], proteome[32] and genome[25] is 
currently underway. The accumulation of multi-tier 
information makes M. extorquens AM1 a model system 
for integrative functional genomic analysis[28] and for 
quantifying changes between methylotrophic versus 
non-methylotrophic growth modes. Stoichiometric 
models have been constructed[33,34]. Furthermore, some 
key questions on the metabolism of C1 carbons and the 
glyoxylate regeneration cycle in M. extorquens AM1 is 
still under active investigation[35] making it an 
interesting as well as a challenging model organism. 
 
1  Methods 
 
1.1  Metabolic network of M. extorquens AM1 
First, we will specify the large metabolic network 
we have been using for validation: the central 
metabolism of M. extorquens AM1(Fig. 1). The key 
pathways represented are formaldehyde metabolism, 
Serine cycle, Tricarboxylic acid (TCA) cycle, Pentose 
phosphate pathway (PPP), Poly-β-hydroxybutyrate 
(PHB) synthesis and Acetyl-CoA conversion pathway, 
gluconeogensis and serine biosynthesis[25].  
  
1.2  Generic kinetic equations 
There is a wide variety of kinetic rate equations  
 
Fig. 1  The main metabolic pathways of Methylobacterium extorquens AM1 
The number with each reaction is its steady state flux calculated from the present kinetic model feeding on methanol (c.f. Table 3) 
 
depending on the type of binding mechanism and the 
type of modifiers. The large number of parameters 
makes it difficult, if at all possible, to determine all 
parameters experimentally. However, it is not always 
necessary to know the full mechanistic rate equation in 
order to correctly characterize the behavior of the 
organism. The reason is that physiologically, metabolite 
concentrations are usually restricted to a rather narrow 
subspace of the whole range of concentrations[36]. 
A chemical reaction can be written in the general 
form of Eq. (1). 
 
V
1 2 m 1 2 nV
A + A +...+ A P + P +...+ PF
B
ˆ ˆ ˆ †‡ ˆ ˆ ˆ  (1) 
Each Ai can be the same chemical species as the 
previous Ai or they can be a different chemical species. 
The same holds for the products P. In this way, the 
stoichiometry is specified. Enzymes catalyze most 
biological reactions. Implicit in the above is an enzyme 
E which appears unbound on both sides of the reaction. 
The chemical reaction presented above does not 
indicate the sequence of reactions and the formation of 
intermediate compounds, such as enzyme- substrate 
complexes. The sequence of reactions leading to the 
enzyme-substrate complex is important when we seek 
to understand the catalytic properties of enzymes. 
Even though various binding mechanisms leading to 
complicated rate equations have been studied in great 
detail[20], these mechanistic rate equations are of less 
practical use. This is because they contains a profusion 
of parameters even for a bi-substrate ordered 
mechanism that are difficult to determine, even for in 
vitro studies of enzymes. Another problem is that even 
though databases of enzyme data have been established, 
there is still a lack of data from enzyme 
characterization under physiologically relevant 
conditions, i.e. with appropriate pH, temperature and 
metabolite pools. Compounding the problem is a lack 
of standardized procedures for reporting results from 
enzyme studies. Various inconsistencies that arise from 
using enzyme databases have been summarized[36]. 
Efforts have been made towards more uniform data 
reporting[37]. 
To alleviate some of the problems we highlighted, 
we use a generic form for the rate equations[38] for the 
set of metabolic reactions in our model. This produces 
a minimal set of relevant parameters for characterizing 
enzymatic reactions. The generic enzymatic rate 
equation, Eq. (2) can be constructed from the general 
chemical equation in Eq. (1). Such equation has been 
motivated by various computational and biological 
considerations, a result of close interaction between the 
experimental and computational efforts. 
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The two functions f1 and f2 have the following 
properties: 
 f1(VF, VB) + f2(VF, VB)=1 (3) 
 f1(VF=0, VB)=0 (4) 
 f2(VF, VB=0)=0 (5) 
The first property is a normalization condition so 
that at very low concentrations of A’s and P’s, the 
denominator is unity. The second property expresses 
the fact that if the reaction is only backward (i.e. VF is 
zero so that the first term in the numerator vanishes), 
the rate should not be affected by the concentration of 
A. Therefore, the first term in the denominator has to be 
zero also. The third property has the same requirement 
as the second property but applies for the case where 
the reaction is irreversible in the backward direction 
(i.e. VB is zero so that the second term in the numerator 
vanishes). The irreversibility is considered in the last 
elementary reaction where the enzyme product 
complex disassociates to give the free enzyme and 
product. We have shown that the full mechanistic rate 
equations can generally be recast into the proposed 
generic form[38]. 
 
1.3  Modifiers: inhibitors and activators 
Modification of a reaction, or its control and 
regulation from an engineering perspective, can be in 
the form of substrate activators or product inhibitors. 
We discuss how they can be included in the generic rate 
equation. In enzyme kinetic studies, there are two 
common types of inhibitors: non-competitive and 
competitive[20]. Competitive inhibitors compete with 
the substrate for binding to the enzyme forming an 
enzyme-inhibitor complex. The inhibitor does not act 
on the enzyme-substrate complex once it is formed. 
The effects of inhibitor on the reaction flux can be 
written in the form 
 
1 ( / )n
v
v
I a
→
+
, (6) 
that is, the left hand of Eq.(2) times the inhibition 
factor, of sigmoidal form, where I is the inhibiting 
product and a is some numerical factor which controls 
how large I has to be before the reaction rate is 
significantly reduced. The power of I in the 
denominator (represented by n) can be modified 
depending on the extent of product inhibition[39] 
desired. As n increases, the function becomes more 
step-like. We do not explicitly specify the type of 
inhibition for the inhibitor modifier that we use in Eq. 
(6). It is clear that we can account for non-competitive 
inhibitors effect since VF is changed by multiplying the 
modifier, same as in Eq. (6). 
The activation can be handled similarly, that is, the 
resulting rate equation takes the form of 
 
( / )
1 ( / )
m
m
X b
v v
X b
→
+
, (7) 
the left hand of Eq.(2) times the activation factor of 
sigmoidal form, and X is the activation product and b 
some numerical factor which controls how large X has 
to be before the reaction rate is significantly reduced 
and m is an integer larger than 1. 
To summarize, we use a generic rate equation for our 
reactions. This general equation requires a minimum 
set of parameters: the maximal forward and backward 
reaction velocity: VF and VB and Ki as the apparent 
Michaelis-Menten parameter for each reactant, which 
defines how close each reactant is to saturation. The 
advantage of using a generic kinetic equation to 
construct metabolic models is obvious. Each reaction 
can be specified in the same way in a parameter file, 
which can be easily interpreted by a computer program. 
We do not have to worry about the different binding 
mechanism with different parameters for each separate 
equation. 
 
1.4  Substrates and metabolites 
The metabolic reaction network consists of 80 
reactions and 80 metabolites. The list of metabolites 
and their corresponding abbreviations is shown in 
Table 1. A few substrates are assumed to be present in 
large excess so we ignored their effects on the reaction 
rates by setting their concentration to be constant. 
Apart from these considerations, we assume that all 
reactions take place in just one compartment within the 
cytoplasm and the reactions inside the cell are not 
restricted by the diffusion process. 
Biomass production was represented as a sum of 20 
key precursors[33]. This is shown in Table 1. Under 
realistic situations, biomass fluxes should depend on 
metabolite availability. If metabolite A is extracted for 
biomass production (i.e. b<0), we model the biomass 
flux for A as 2b[A] / ([A]0+[A]) where [A]0 is the 
expected steady state concentration of metabolite A. On 
the other hand, if metabolite B comes from biomass 
production (i.e. b>0), we model the biomass flux for B 
as 2b[B]0/([B]0+[B]) where [B]0 is the expected steady 
state concentration of metabolite B.  
When the metabolite concentrations reaches the 
expected steady state, i.e. [A]=[A]0 and [B]=[B]0, we 
see that the biomass flux is exactly b. 
 Table 1  List of metabolites in Methylobacterium extorquens AM1 central metabolism and steady  
state concentrations of kinetic model 
# Metabolites Abbreviation Biomass 
composition, b
 
Steady state concentration, x0 
(mmol/L) 
1 Nicotinamide adenine dinucleotide NAD −5 1.69 
2 Formaldehyde HCHO 0 0.01 
3 5,10-Methylene-tetrahydrofolate Methylene-H4F 0 0.07 
4 5,10-Methenyl-tetrahydrofolate Methenyl-H4F 0 0.07 
5 Nicotinamide adenine dinucleotide phosphate NADP 257 0.62 
6 Formyl-tetrahydromethanopterin Formyl-H4F 0 0.07 
7 Formate Formate 0 2.00 
8 Adenosine triphosphate ATP −585 2.88 
9 5,10-Methylene-tetrahydromethanopterin Methylene-H4MPT 0 0.20 
10 5,10-Methenyl-tetrahydromethanopterin Methenyl-H4MPT 0 0.20 
11 Formyl-tetrahydromethanopterin Formyl-H4MPT 0 0.02 
12 Formylmethanofuran FMR 0 0.01 
13 Glycine Gly −13 16.58 
14 Serine Ser −7 4.90 
15 Glyoxylate Glyox 0 12.60 
16 Hydropyruvate h-pyruvate 0 1.40 
17 Glycerate Glycerate 0 2.22 
18 3-phosphoglycerate 3-PG 0 2.36 
19 2-phosphoglycerate 2-PG 0 2.19 
20 Phosphoenolpyruvate PEP −11 6.00 
21 Oxaloacetate OAA −41 7.35 
22 Malate Malate 0 1.60 
23 Malyl-CoA Malyl-CoA 0 3.43 
24 Acetyl-CoA Acetyl-CoA −53 0.38 
25 Pyruvate Pyr −42 3.85 
26 Coenzyme A CoA 60 0.10 
27 Citrate Cit 0 4.74 
28 Cis-aconitate Cis-acon 0 1.00 
29 Isocitrate Iso-C 0 1.00 
30 Alpha-Ketoglutarate α-KG −17 0.65 
31 Succinyl-CoA Succ-CoA −7 0.65 
32 Guanosine diphosphate GDP 0 0.11 
33 Succinate Succ 7 11.77 
34 Fumarate Fum 0 0.51 
35 Flavin adenine dinucleotide FAD 0 0.99 
36 Glucose 6-phosphate Glc6P 0 4.20 
37 Fructose 6-phosphate Fru6P −16 6.36 
38 Fructose 1,6-biphosphate Fru (1,6)-BP 0 2.00 
39 Dihydroxyacetone phosphate DHAP 0 12.36 
40 Glyceraldehyde 3-phosphate TP −2 12.41 
41 1,3-biphosphoglycerate 1,3-BPG 0 11.31 
42 6-phosphogluconate 6-PG 0 2.00 
43 Ribose 5-phosphate Ribose5P −10 4.51 
44 Ribulose 5-phosphate Ribu5P 0 4.51 
(to be continued on the next page) 
 (Continued) 
  
# Metabolites Abbreviation Biomass 
composition, b
 
Steady state concentration, x0 
(mmol/L) 
45 Xylulose 5-phosphate Xy5P 0 1.80 
46 Sedoheptolose-7-phosphate Sedo7P 0 1.85 
47 Erythrose-4-phosphate Ery4P −5 3.59 
48 Acetoacetyl-CoA Acetoac-CoA 0 0.18 
49 β-hydroxybutyrate-CoA 3HB-CoA 0 0.03 
50 Poly-β-hydroxybutyrate PHB −93 0.12 
51 β-hydroxybutyrate 3HB 0 1.16 
52 Acetoacetate Acetoac 0 0.85 
53 Crotonyl-CoA Crot-CoA 0 0.01 
54 (L)-β-hydroxybutyryl-CoA L3HB-CoA 0 0.24 
55 Butyryl-CoA But-CoA 0 0.22 
56 Propionyl-CoA Prop-CoA 0 0.09 
57 Methylmalonyl-CoA Mema-Coa 0 0.27 
58 3-phosphohydroxypyruvate PHP 0 0.60 
59 3-Phosphoserine 3Pser 0 0.09 
60 Glutamate Glu −17 12.00 
61 Ubiquinone Q 0 0.98 
62 Cytochrome-c (oxidized) Cyt-Cox 0 1.00 
63 Nicotinamide adenine dinucleotide (reduced) NADH 5 0.53 
64 Nicotinamide adenine dinucleotide phosphate (reduced) NADPH −257 0.42 
65 Adenosine diphosphate ADP 585 0.60 
66 Guanosine triphosphate GTP 0 0.99 
67 Flavin adenine dinucleotide (reduced) FADH2 0 0.11 
68 Ubiquinol QH2 0 1.02 
69 Cytochrome-c (reduced) Cyt-Cred 0 1.00 
70 Methanol MeOH 0 100.00 
71 Tetrahydrofolate H4F 0 0.07 
72 Tetrahydromethanopterin H4MPT 0 0.20 
73 Carbon dioxide CO2 0 5.00 
74 Ammonia NH3 0 1.00 
75 Methanofuran MFR 0 0.40 
76 Phosphate Pi 0 3.00 
77 Proton H 0 6.31 
78 External Pyruvate Py-Out 0 N/A 
79 External Succinate Succ-Out 0 N/A 
80 Electron e 0 0.00 
MeOH, H4F, H4MPT, methanofuran, CO2, NH3, Pi, CoA, Cyt-cox, Cyt-cred, pyruvate-uut, succinate-out are constants. Another set of constants (in 
mmol/L) are NAD + NADH=2.22, NADP + NADPH =1.04, ATP + ADP =3.48, GDP + GTP =1.1, FAD + FADH2=1.1, Q + QH2 = 2.0 
 
 
The biomass flux is also flexible in that if more of 
metabolite [A] (relative to the expected steady state 
level) is available, a larger portion is extracted for 
biomass production.  A lesser portion is extracted 
when the concentration of A falls below the expected 
steady state level. 
 
1.5  Incorporation of fluxes and metabolite 
concentrations a priori to determine parameters for 
enzymatic rate equations 
We start by analyzing the fluxes obtained from 
enzymatic rate equations. For the purpose of 
demonstration, consider a reversible reaction among 
two metabolites, A ↔ B: 
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here 
 f1=VF2/(VF2+VB2), f2= VB2/( VF2+VB2) 
If we require the flux ν to be the expected steady 
state value when the metabolite concentrations are the 
expected steady state values, the above equation 
constrains the allowed choices of VF, VB, KA, KB. If 
experimental values of KA, KB, Keq = (VF/ KA) /(VB/ KB), 
are known, then the above equation allows the 
determination of VF. If KA, KB, Keq are not measured, 
according to biochemical observation and the 
optimization principle we presented, later, we propose 
to choose KA, KB in the range of steady state metabolite 
concentrations. Forsimplicity, we choose KA=[A]0, 
KB=[B]0, where [A]0 and [B]0 are desired steady state 
concentrations. Our optimization analysis also 
demonstrates that the equilibrium constant Keq = (VF/KA) 
/(VB/KB) is optimized on the order of [B]0/[A]0. When 
considering thermodynamic constrains on Keq, such an 
optimization could be interpreted as optimization of the 
metabolite concentrations. For simplicity we choose 
Keq = 2 [B]0/[A]0 
for forward reactions, ν0 > 0 and 
Keq = 0.5 [B]0/[A]0 
for backward reactions, v0 < 0. 
By using these KA, KB, Keq, VF are determined. 
In summary, we demonstrate that how parameters in 
the enzymatic rate equations VF, VB, KA, KB are 
determined by requiring steady state fluxes and steady 
state metabolites concentrations, together with the 
requirement that KA, KB and Keq take values in the range 
of metabolite concentrations. Reactions involving more 
metabolites with inhibitors and activators can be 
determined in a similar manner. 
 
1.6  Optimization of K’s and K’eqs based on 
fluctuation minimization 
First consider an irreversible reaction A→. The 
generic rate equation is given by 
 
[ ] /
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+
 (9) 
We calculate how the enzymatic rate changes with 
disturbances of metabolite concentration. If metabolite 
concentration deviates by δ[A], then the relative change 
of the flux is given by δlnν = (∂lnν/∂ln[A]) δln[A]. If, 
on the other hand, flux changes by an amount δν, for 
instance due to the change of reaction which produces 
metabolite A, the amount of relative change in 
metabolite is given by δln[A]= (∂ln[A]/ ∂lnν)δlnν. For 
the stability of the metabolic network, both these 
changes should be kept small. Since the coefficients 
(∂lnν/∂ln[A]) and (∂ln[A]/∂lnν) are reciprocal to each 
other, compromises need to be made. Carrying out 
calculations we have 
 
ln
ln[ ]
A
A
Kv
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∂
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∂ +
, (10) 
which changes from 0 to 1 with KA increasing from 
0 to ∞ , and 
 
ln[ ]
ln
A
A
K AA
v K
+∂
=
∂
, (11) 
which changes from ∞ to 1 with increasing KA from 
0 to ∞. The choice of KA ~ [A] is apparently a good 
compromise because it makes both (∂lnν/∂ln[A]) and 
(∂ln[A]/∂lnν) reasonably small. For simplicity we choose 
KA = [A]0, where [A]0 is the expected steady state value. 
With this choice, the steady state flux is v0 = VF/2. 
Therefore for consistency, VF should be chosen as 2ν0. 
Next we consider a reversible reaction 
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With 
f1=VF2/(VF2+VB2), f2=VB2/(VF2+VB2) 
and  v>0. 
We present an intuitive approach to analyze such a 
reaction. We assume the reaction as forward (v>0) and 
for approximation, we ignore the backward reaction 
when choosing the forward reaction constants KA and 
VF. This gives Vf=2ν0 and KA=[A]0, according to the 
results presented above for the case of A→. 
Considering that metabolite A is at its steady state 
value [A] = [A]0 so that the focus of the rate equation is 
only on [B], we have a simplified relationship 
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We now require the absolute values of both 
(∂lnν/∂ln[B]) and (∂ln[B]/∂lnν) to be small to avoid 
large fluctuations due to δln[B] and δlnν. Carrying out 
the calculation we have 
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and ∂ln[B]/∂lnν = 1/ (∂lnν/∂ln[B]). 
The values of ∂ln[B]/∂lnν are −∞ both when KB=0 
and KB=∞. Apparently some physiological value of KB 
between 0 and ∞ is needed to avoid large fluctuations 
due to ∂ln[B]/∂lnν. A choice of ∂ln[B]/∂lnν = 
−20/11≈−1.82 will satisfy such a requirement. There 
are positive solutions for KB for any given VB, when VB 
is in a wide range of values, since ∂ln[B]/∂lnν = −20/11 
is a polynomial equation of second order for KB if VB is 
treated as a constant. For example if VB = ν0, then 
KB=[B]0 is a solution for ∂ln[B]/∂lnν =−20/11. In such a 
  
case large fluctuations of δln[B]=(∂ln[B]/∂lnν) δlnν and 
δν=(∂lnν/∂ln[B]) δln[B] are all avoided. 
Next we need to find if there is any reason to choose 
VB=ν0 from optimization of enzyme functions. For the 
purpose of examining the enzyme performance due to 
variation in VB, we let KA=[A]0 KB=[B]0, then at the 
steady state, the flux is simply given by ν = (VF−VB)/2. 
The change of ν due to change of VB is δlnν= 
(∂lnν/∂lnVB) δlnVB, with (∂lnν/∂lnVB)=−VB/2ν0, 
assuming ν=ν0. If VB fluctuates, for instance due to pH 
values, then ν changes accordingly. 
If both VF and VB are very large compared with ν0 so 
that ν0 = (VF−VB)/2 is the result of large forward and 
backward reactions subtracting each other, for instance 
VF=1002ν0 and VB=1000ν0, ν0 = (VF−VB)/2 = 
(10002ν0−1000ν0)/2, the fluctuation of ν due to 
fluctuation of VB is large because δlnν= (∂lnν/∂lnVB) 
δlnVB =−(VB/2ν0)δlnVB =−500 δlnVB. Such an enzyme 
is not optimized with respect to fluctuations of VB. On 
the other hand, VB should not be too small because if 
VB=0, then this reaction is essentially an irreversible 
one, resulting in a divergent equilibrium constant 
Keq=(VF/KA)/(VB/KB), inconsistent with the assumption of 
a reversible reaction.  
With these complex relationships concerning 
fluctuation and thermodynamic restriction of 
equilibrium constant, a consistent choice for the 
enzyme is to have VB on the order of physiological flux 
ν0, which also needs VF on the order of ν0 because of 
the relationship ν0 = (VF−VB)/2.  In such a way, 
fluctuations due to the change of VB are small while the 
equilibrium constant Keq = (VF/KA)/(VB/KB) can be 
maintained at the desired value of Keq = (VF/[A]0)/ 
(VB/[B]0) by adjusting steady state metabolite 
concentrations [A]0, [B]0. 
Finally, the above discussion can be formalized by 
designing a cost function to minimize fluctuations in 
fluxes due to relative changes in metabolite 
concentrations [A] and [B], in Vf and VB, and 
fluctuations of metabolite concentrations due to 
changes in fluxes simultaneously. We have performed 
such an optimization process. Since it is only a 
formalization of the analysis presented in this section, 
the qualitative results are the same. We will not present 
such an approach here. 
To summarize, we have demonstrated that the choices 
of KA, KB, Keq, in the physiological range of [A]0, [B]0 and 
[B]0/[A]0 are optimized for minimizing fluctuations. For 
simplicity we use KA=[A]0 , KB=[B]0, and Keq=2[B]0/[A]0 
in our model. For reactions involving more metabolites, 
similar analysis can be carried through. We found that the 
results are similar, which is reasonable because the 
generic rate equation has the same form. The principle 
behind the approach in this section is essentially a 
matching condition similar to the Hebbian learning rule in 
neurodynamics[40]. 
 
1.7  Coupling to the rest of the metabolic network 
not included in the model 
In many cases, we wish to model a particular section 
of the metabolic network instead of the whole network 
in the organism. For example, most of the experimental 
works on M. extorquens AM1 have been concentrated 
on central metabolism of this bacterium[25]. Therefore a 
kinetic model of M. extorquens AM1 central 
metabolism is useful at this stage. When modeling only 
part of the metabolic network, its coupling to the rest of 
metabolic network not included in the model should 
contain both the steady state values of fluxes in and out 
of the metabolic system in the model and their 
dynamics.  
First consider a situation when two metabolites, A 
within the model and B not, are coupled with a 
reversible reaction A↔B with ν>0. Since B is not 
included in the model, this reaction is not included 
either. Instead we consider that a flux fA is taking out A, 
e.g. for biomass synthesis, in the kinetic equation of 
metabolite [A] by subtracting a term ηfA[A] /(k + [A]), 
where η= (k + [A]0)/ [A]0, [A]0 the expected steady state 
value of [A]. Such a subtraction is more realistic than 
simply subtracting fA, because if metabolite B were 
included in the model, there would be term 
representing A↔B in the kinetic equation of metabolite 
[A], which is a subtraction of similar form. Therefore 
we propose when there is a flux taken out of the system, 
this form should be used for coupling. For simplicity 
we choose k=
 
[A]0 and η=2. 
Next consider for metabolites A and B connected 
with a reaction A↔B with ν>0, and B is within the 
model while A is not. At steady state there is a constant 
input of flux from A to B into the system in the model. 
Now consider the rate equation for A↔B, the flux 
added in to B is in the form of (µ - ν[B] )/f([B]), with µ 
and ν constants and f([B]) a function of [B]. A form to 
mimic such coupling is a function η′ fB /( k′ + [B]), 
with η′= k′ + [B]0, [B]0 the expected steady state value 
of [B], fB the flux adding to B. Again for simplicity we 
choose k′=
 
[B]0 and η′=2 [B]0. 
To summarize, if a flux fA is taking out from metabolite 
A to be used beyond the modeled system, we subtract a 
term 2fA[A] /([A]0 + [A]) from the dynamic equation of 
[A]. If a flux fB is adding to metabolite B from sources 
outside the modeled system, we add a term 2fB[B]0 /([B]0 
+ [B]) to the dynamic equation of [B]. 
 
1.8  Central Metabolism of M. extorquens AM1 
Methylotrophic bacterium M. extorquens AM1 is a 
well studied facultative methylotroph[25,33] which utilizes 
 both single and multiple carbon unit compounds. The 
central metabolism adjusts to growth in different 
conditions by changing expression of enzymes under 
different growth conditions[25,33]. The metabolic pathways 
necessary for energy balance and growth need for carbon 
under methylotropic growth conditions are included in 
our model, including formaldehyde metabolism[41], the 
serine cycle[42], the citric acid cycle, the pentose phosphate 
pathway, poly-β-hydroxybutyrate (PHB) synthesis, the 
gloxylate regeneration cycle[43,44], gluconeogenesis, serine 
biosynthesis and respiratory chain. 
Under methylotropic growth conditions, the serine 
cycle is utilized for C1 assimilation as follows: methanol 
(MeOH), a C1 compound is first oxidized to 
formaldehyde by the methanol dehydrogenase complex in 
the periplasm. The formaldehyde that enters the 
cytoplasm condenses with either tetrahydrofolate (H4F) or 
tetrahydromethanopterin (H4MPT) to form the respective 
methylene derivatives. The reaction of formaldehyde with 
H4F to produce methylene-H4F is considered a 
spontaneous reaction since no enzyme that catalyzes this 
reaction has been found thus far. Methylene-H4F is either 
assimilated through the serine cycle or oxidized to 
methenyl-H4F, formyl-H4F and eventually to formate. 
Formate is further oxidized to CO2 by formate 
dehydrogenases in an energy-generating 
reaction.  Alternatively, formaldehyde is oxidized via the 
H4MPT-linked pathway. In the initial step for this pathway, 
formaldehyde reacts with H4MPT to form Methylene- 
H4MPT. 
M. extorquens AM1 has a complete citric acid cycle 
since it can grow on alternative carbon source such as 
pyruvate. The citric acid cycle is dispensable under C1 
growth condition as indicated by mutants that lack 
α-KG dehydrogenase activity[45]. The citric acid cycle 
overlaps in part with the gloxylate regeneration cycle, 
which converts acetyl-CoA to glyoxylate to maintain 
the serine cycle. The glyoxylate regeneration cycle also 
overlaps with PHB synthesis. 
 
2  Results and discussions 
 
2.1  Kinetic equations for metabolic network 
After going though the procedure described above, a 
set of dynamical equations corresponding to the reactions 
of the metabolic network can be explicitly obtained, 
which are in the form of differential equations and may be 
written as 
 ( ) ( )dx Sv x b x
dt
= +  (15) 
where x(t) is a vector of metabolite concentration at 
time t with dimensions 80×1. S is the stoichiometric 
matrix with dimensions 80×80. v is a vector 
(dimensions 80×1) containing the reaction rate or 
fluxes and is a function of x(t), the metabolite 
concentration at time t. The vector b(x) is the flux for 
biomass production as described in Sec. 2.4. x 
represents the state of the system. The differential 
equations are tabulated in Table 2 in the stoichiometric 
form, and the kinetic parameters are given in Table 3 
contains the references[46−53]. 
Starting from an initial condition x0, the set of 
differential equations is integrated numerically in Matlab 
using the ordinary differential solver, ode15s until we 
reach a steady state solution, x(tfinal). The set of steady 
state fluxes can be obtained by substituting the final 
metabolite concentrations, x into v. We present our results 
from the kinetic simulation in the next section. 
With the explicitly mathematical representation of 
the metabolic network, various predictions can be 
obtained via standard mathematical tools which are 
usually available in Matlab or MATHEMATICA. An 
initial set of an exploration will be given below to show 
the feasibility of our present method. 
 
2.2  Fluxes and concentrations 
From our kinetic simulation, the flux distribution and 
metabolites concentrations can be predicted as a function 
of time. The predicted steady state flux distribution when 
growing on methanol is shown in Fig. 1 which can be 
obtained by methods based on FBA. The predicted steady 
state concentrations are in Table 1. The set of fluxes is 
shown in Table 3. The predicted TCA cycle fluxes are 
smaller compared to the predicted fluxes in the glyoxylate 
cycle. Some fluxes of central carbon metabolism with 
methanol as a substrate have been measured[54]. Low 
fluxes were detected through pyruvate dehydrogenase 
(Reaction No. 24, Table 3), α-KG dehydrogenase 
(Reaction no. 29, Table 3) and malic enzyme (Reaction 
No. 42, Table 3) for the wild-type  M. extorquens AM1 
growing on methanol. 
Table 2  Kinetic Equations for Methylobacterium extorquens AM1 central metabolic network 
in explicit stoichiometric form 
Variable Metabolite Kinetic equation
 
Variable Metabolite Kinetic equation
 
x1 NAD 
dx1/dt = −ν6−ν8 +ν15 +ν21 −ν24 −ν29 −ν37 
−ν42 −ν54 −ν58 −ν60 −ν63 +ν67 +ν73 −ν78 +b1 
x41 1,3-BPG dx41/dt = ν37 +ν38 +b41 
x2 HCHO dx2/dt = ν1 −ν2 −ν7 +b2 x42 6-PG dx42/dt = ν43 −ν44 +b42 
x3 Methylene-H4F dx3/dt = ν2 +ν3 −ν13 +ν78 +b3  x43 Ribose5P dx43/dt = ν44 −ν45 −ν47 +b43 
  
x4 Methenyl-H4F dx4/dt = −ν3 −ν4 +b4 x44 Ribu5P dx44/dt = ν45 −ν46 +b44 
x5 NADP 
dx5/dt = ν3 −ν9 +ν16 −ν28 −ν43 −ν44 +ν51+ν59 
−ν66 +ν72 −ν73 +b5 
x45 Xy5P dx45/dt = ν46 −ν47 −ν49 +b45 
x6 Formyl-H4F dx6/dt = ν4 +ν5 +b6 x46 Sedo7P dx46/dt = ν47 −ν48 +b46 
x7 Formate dx7/dt = −ν5 −ν6 +ν12 +b7 x47 Ery4P dx47/dt = ν48 −ν49 +b47 
x8 ATP 
dx8/dt = −ν5 −ν17 −ν22 −ν38 −ν40 +ν41 −ν61 
−ν70 −ν71 −ν77 +b8 
x48 Acetoac-CoA dx48/dt = ν50 −ν51 +ν55 +ν58 +ν77 +b48 
x9 Methylene-H4MPT dx9/dt = ν7 −ν8 −ν9 +b9 x49 3HB-CoA dx49/dt = ν51 −ν52 +ν56 +b49 
x10 Methenyl-H4MPT dx10/dt = ν8 +ν9 −ν10 +b10 x50 PHB dx50/dt = ν52 −ν53 +b50 
x11 Formyl-H4MPT dx11/dt = ν10 −ν11 +b11 x51 3HB dx51/dt = ν53 −ν54 +b51 
x12 FMR dx12/dt = ν11 −ν12 +b12 x52 Acetoac dx52/dt = ν54 −ν55 −ν77 +b52 
x13 Gly dx13/dt = −ν13 +ν14 −ν78 +b13 x53 Crot-CoA dx53/dt = −ν56 +ν57 −ν59 +b53 
x14 Ser dx14/dt = ν13 −ν14 +ν65 −ν76 +b14 x54 L3HB-CoA dx54/dt = −ν57 −ν58 +b54 
x15 Glyox dx15/dt = −ν14 −ν23 −2 ν75 +b15 x55 But-CoA dx55/dt = ν59 −ν60 +b55 
x16 h-pyruvate dx16/dt = ν14 −ν15 −ν16 +ν75 +b16 x56 Prop-CoA dx56/dt = ν60 −ν61 +b56 
x17 Glycerate dx17/dt = ν15 +ν16 −ν17 +b17 x57 Mema-Coa dx57/dt = ν61 −ν62 +b57 
x18 3-PG dx18/dt = ν18 −ν38 −ν63 +b18 x58 PHP dx58/dt = ν63 −ν64 +b58 
x19 2-PG dx19/dt = ν17 −ν18 −ν19 +b19 x59 3Pser dx59/dt = ν64 −ν65 +b59 
x20 PEP dx20/dt = ν19 −ν20 +ν39 −ν41 +b20 x60 Glu dx60/dt = −ν64 −ν66 +b60 
x21 OAA dx21/dt = ν20 −ν21 −ν25 −ν39 +ν40 +b21 x61 Q dx61/dt = −ν67 +ν68 −ν69 −ν72 −ν74 +b61 
x22 Malate dx22/dt = ν21 −ν22 +ν32 −ν42 +b22 x62 Cyt-Cox dx62/dt = 0 
x23 Malyl-CoA dx23/dt = ν22 +ν23 +b23 x63 NADH 
dx63/dt = ν6 +ν8 −ν15 −ν21 +ν24 +ν29 
+ν37 +ν42 +ν54 +ν58 +ν60 +ν63 −ν67 −ν73 
+ν78 +b63 
x24 Acetyl-CoA dx24/dt = −ν23 +ν24 −ν25 −2 ν50 +b24 x64 NADPH 
dx64/dt = −ν3 +ν9 −ν16 +ν28 +ν43 +ν44 
−ν51 −ν59 +ν66 −ν72 +ν73 +b64 
x25 Pyr dx25/dt = −ν24 −ν40 +ν41 +ν42 +ν76 +ν79 +b25 x65 ADP dx65/dt = ν5 +ν17 +ν22 +ν38 +ν40 −ν41 +ν61 +ν70 +ν71 +ν77 +b65 
x26 CoA dx26/dt = 0 x66 GTP dx66/dt = −ν30 −ν39 +ν71 +b66 
x27 Cit dx27/dt = ν25 +ν26 +b27 x67 FADH2 dx67/dt = −ν31 +ν60 −ν69 +b67 
x28 Cis-acon dx28/dt = −ν26 +ν27 +b28 x68 QH2 dx68/dt = ν67 −ν68 +ν69 +ν72 +ν74 +b68 
x29 Iso-C dx29/dt = −ν27 −ν28 +b29 x69 Cyt-Cred dx69/dt = 0 
x30 α-KG dx30/dt = ν28 −ν29 +ν64 +ν66 +b30 x70 MeOH dx70/dt = 0 
x31 Succ-CoA dx31/dt = ν29 +ν30 −ν55 +ν62 +b31 x71 H4F dx71/dt = 0 
x32 GDP dx32/dt = ν30 +ν39 −ν71 +b32 x72 H4MPT dx72/dt = 0 
x33 Succ dx33/dt = −ν30 +ν31 +ν55 +ν80 +b33 x73 CO2 dx73/dt = 0 
x34 Fum dx34/dt = −ν31 −ν32 +b34 x74 NH3 dx74/dt = 0 
x35 FAD dx35/dt = ν31 −ν60 +ν69 +b35 x75 MFR dx75/dt = 0 
x36 Glc6P dx36/dt = −ν33 −ν43 +b36 x76 Pi dx76/dt = 0 
x37 Fru6P dx37/dt = ν33 +ν34 +ν48 +ν49 +b37 x77 H dx77/dt = −ν67 +2 ν78 +2 ν70 −ν72 +b77 
x38 Fru(1,6)-BP dx38/dt = −ν34 −ν35 +b38 x78 Py-Out dx78/dt = 0 
x39 DHAP dx39/dt = ν35 +ν36 +b39 x79 Succ-Out dx79/dt = 0 
x40 TP dx40/dt = ν35 −ν36 −ν37 +ν47 −ν48 +ν49 +b40 x80 E dx80/dt = 2 ν1 −2 ν74 +b80 
Vector x stands for the metabolite concentrations, i.e., x3 = [Methylene–H4F], x5 = [NADP], x48 = [Acetoac–CoA] 
Table 3  Kinetic parameters for the dynamical model of AM1 central metabolic network and the steady state fluxes 
Reactions VF VB K1 K2 K3 K1' K2' K3' i1 i2 i3 j1' j2' j3' s.s.f 
1 MeOH→HCHO+2e 2.97 0 10 0 0 0 0 0 70 0 0 2 81 81 1.04 
2 HCHO+H4F→methylene-H4F 103 0 100 100 0 0 0 0 2 71 0 3 0 0 0.00 
3 Methenyl-H4F+NADPH↔Methylene-H4F+ NADP 1.46 0.365 0.03 0.01 0 0.03 0.01 0 4 64 0 3 5 0 0.61 
4 Methenyl-H4F↔Formyl-H4F 1.55 2.86 0.08 0 0 0.08 0 0 4 0 0 6 0 0 −0.61 
5 Formate+ATP+H4F↔Formyl-H4F+ADP+Pi 16.0 0.0352 22 0.021 0.08 0.08 0.021 2 7 8 71 6 65 76 0.61 
 6 Formate+NAD→NADH+CO2 0.804 0 1.6 0.07 0 0 0 0 7 1 0 63 73 0 0.43 
7 HCHO+H4MPT→Methylene-H4MPT 33.8 0 0.2 0.1 0 0 0 0 2 72 0 9 0 0 1.04 
8 Methylene-H4MPT+NAD↔Methenyl-H4MPT+ 
NADH 0.876 0.0201 0.05 0.2 0 0.2 0.2 0 9 1 0 10 63 0 0.63 
9 Methylene-H4MPT+NADP↔Methenyl-H4MPT+ 
NADPH 0.648 0.00745 0.1 0.02 0 0.2 0.02 0 9 5 0 10 64 0 0.42 
10 Methenyl-H4MPT↔formyl-H4MPT 0.372 18.1 0.03 0 0 0.2 0 0 10 0 0 11 0 0 1.04 
11 Methanofuran+formyl-H4MPT↔FMR+H4MPT 17.5 3.57 0.05 0.2 0 0.05 0.2 0 75 11 0 12 72 0 1.04 
12 Formylmethanofuran→Formate 6.26 0 0.05 0 0 0 0 0 12 0 0 7 0 0 1.04 
13 Methylene-H4F+glycine↔Serine+H4F 4.91 2.46 0.07 16.6 0 4.89 0.07 0 3 13 0 14 71 0 0.61 
14 Serine+glyoxylate↔glycine+hydroxypyruvate 4.95 2.48 4.89 12.6 0 16.6 1.4 0 14 15 0 13 16 0 0.62 
15 Hydroxypyruvate+NADH↔glycerate+NAD+ 4.95 2.48 1.4 0.53 0 2.22 1.69 0 16 63 0 17 1 0 0.62 
16 Hdroxypyruvate+NADPH↔glycerate+NADP 0 0 1.4 0.42 0 2.22 0.62 0 16 64 0 17 5 0 0 
17 Glycerate+ATP→2-phosphoglycerate+ADP+Pi 2.48 0 2.22 2.88 0 0 0 0 17 8 0 19 65 76 0.62 
18 2-PG↔3-PG 0.134 0.0668 2.19 0 0 2.36 0 0 19 0 0 18 0 0 0.03 
19 2-PG↔phosphoenolpyruvate 2.34 1.17 2.19 0 0 6 0 0 19 0 0 20 0 0 0.59 
20 Phosphoenolpyruvate+CO2↔Oxaloacetate+Pi 1.46 0.731 6 0 0 7.34 0 0 20 73 0 21 76 0 0.37 
21 Oxaloacetate+NADH→malate+NAD 0.821 0 7.34 0.53 0 1.6 1.69 0 21 63 0 22 1 0 0.21 
22 Malate+ATP+CoA→malyl-CoA+ADP+Pi 21.1 0 1.6 2.88 0.1 3.43 0.6 3 22 8 26 23 65 76 0.62 
23 Glyoxylate+Acetyl CoA↔Malyl-CoA 1.49 2.98 12.61 0.38 0 3.43 0 0 15 24 0 23 0 0 −0.62 
24 Pyruvate+CoA+NAD→acetyl CoA+CO2+NADH 2.73 0 3.85 0.1 1.69 0 0 0 25 26 1 24 73 63 0.33 
25 Acetyl CoA+OAA→citrate+CoA 0.361 0 0.38 7.34 0 0 0 0 24 21 0 27 26 0 0.03 
26 Cis-aconitate↔Citrate 0.0556 0.111 1 0 0 4.74 0 0 28 0 0 27 0 0 −0.03 
27 Isocitrate↔cis-aconitate 0.0556 0.111 1 0 0 1 0 0 29 0 0 28 0 0 −0.03 
28 Isocitrate+NADP↔a-KG+NADPH+CO2 0.222 0.111 1 0.62 0 0.65 0.42 0 29 5 0 30 64 73 0.03 
29 a-KG+NAD+CoA→succinyl CoA+CO2+NADH 0.124 0 0.65 1.69 0.1 0 0 0 30 1 26 31 73 63 0.01 
30 Succinate+GTP+CoA↔succinyl CoA+Pi+GDP 3.40 6.80 11.8 0.99 0.1 0.65 3 0.11 33 66 26 31 76 32 −0.43 
31 Fumarate+FADH2↔Succinate+FAD 1.71 3.43 0.51 0.11 0 11.8 0.99 0 34 67 0 33 35 0 −0.43 
32 Fumarate↔Malate 1.70 0.85 0.51 0 0 1.6 0 0 34 0 0 22 0 0 0.43 
33 Glc6P↔Fru6P 0.00646 0.0129 4.2 0 0 6.36 0 0 36 0 0 37 0 0 0.00 
34 Fru(1 6)P2→Fru6P+Pi 0.0304 0 2 0 0 6.36 0 0 38 0 0 37 76 0 0.01 
35 Fru(1 6)P2↔dihydroxyacteone phosphate+TP 0.0390 0.0779 2 0 0 12.4 12.4 0 38 0 0 39 40 0 −0.01 
36 TP↔Dihydroxyacteone phosphate 0.0432 0.0216 12.4 0 0 12.4 0 0 40 0 0 39 0 0 0.01 
37 TP+Pi+NAD↔1 3)-DPG+NADH 0.115 0.231 12.4 3 1.69 11.3 0.53 0 40 76 1 41 63 0 −0.02 
38 3-PG+ATP↔1 3)-DPG+ADP 0.192 0.0959 2.36 2.88 0 11.3 0.6 0 18 8 0 41 65 0 0.02 
39 OAA+GTP↔PEP+GDP+CO2 0.0823 0.0412 7.34 0.99 0 6 0.11 0 21 66 0 20 32 73 0.01 
40 Pyruvate+CO2+ATP↔OAA+ADP+Pi 0.845 1.69 3.85 5 2.88 7.34 0.6 3 25 73 8 21 65 76 -0.11 
41 PEP+ADP→pyruvate+ATP 1.79 0 6 0.6 0 0 0 0 20 65 0 25 8 0 0.23 
42 Malate+NAD→pyruvate+CO2+NADH 0.804 0 1.6 1.69 0 0 0 0 22 1 0 25 73 63 0.01 
(to be continued on the next page) 
 
(Continued) 
Reactions VF VB K1 K2 K3 K1' K2' K3' i1 i2 i3 j1' j2' j3' s.s.f 
43 Glc6P+NADP→6-PG+NADPH 0.0397 0 4.2 0.62 0 0 0 0 36 5 0 42 64 0 0.00 
44 6-PG+NADP→ribose 5-phosphate+CO2+NADPH 0.0129 0 2 0.62 0 0 0 0 42 5 0 43 73 64 0.00 
45 Ribose 5-phosphate↔ribulose 5-phosphate 0.00236 0.00472 4.51 0 0 4.51 0 0 43 0 0 44 0 0 0.00 
46 Ribulose 5-phosphate↔xylulose 5-phosphate 0.00236 0.00472 4.51 0 0 1.8 0 0 44 0 0 45 0 0 0.00 
47 Xylulose 5-phosphate+ribose 5-phosphate↔S7P+TP 0.00327 0.00163 1.8 4.51 0 1.85 12.4 0 45 43 0 46 40 0 0.00 
48 S7P+TP↔Fru-6P+Ery-4P 0.00329 0.00164 1.85 12.4 0 6.36 3.59 0 46 40 0 37 47 0 0.00 
  
49 Xylulose 5-phosphate+Ery-4P↔Fru-6P+TP 0.00636 0.0127 1.8 3.59 0 6.36 12.4 0 45 47 0 37 40 0 0.00 
50 2Acetyl CoA↔Acetoac CoA+CoA 3.64 1.82 0.38 0.38 0 0.18 0.1 0 24 24 0 48 26 0 0.45 
51 Acetoac CoA+NADPH↔3HB-CoA+NADP 2.88 1.44 0.18 0.42 0 0.03 0.62 0 48 64 0 49 5 0 0.42 
52 3HB-CoA↔PHB+CoA 0.400 0.200 0.03 0 0 0.12 0.1 0 49 0 0 50 26 0 0.06 
53 PHB→3HB 0.0508 0 0.12 0 0 1.16 0 0 50 0 0 51 0 0 0.03 
54 3HB+NAD↔Acetoac+NADH 0.204 0.102 1.16 1.69 0 0.85 0.53 0 51 1 0 52 63 0 0.03 
55 Acetoac+succinyl CoA↔Acetoac CoA+succinate 0.0322 0.0644 0.85 0.65 0 0.18 11.8 0 52 31 0 48 33 0 -0.01 
56 Crot-Coa↔3HB-Coa 2.67 5.34 0.01 0 0 0.03 0 0 53 0 0 49 0 0 -0.36 
57 L3HB-Coa↔Crot-Coa 0.404 0.202 0.24 0 0 0.01 0 0 54 0 0 53 0 0 0.05 
58 L3HB-Coa+NAD↔Acetoac CoA+NADH 0.206 0.412 0.24 1.69 0 0.18 0.53 0 54 1 0 48 63 0 -0.05 
59 Crot-Coa+NADPH↔but-COA+NADP 2.04 1.02 0.01 0.42 0 0.22 0.62 0 53 64 0 55 5 0 0.41 
60 But-CoA+FAD+2NAD→prop-CoA+FADH+ 
2NADH+ CO2 
6.62 0 0.22 0.99 1.69 0 0 0 55 35 1(1) 56 67 63 0.41 
61 Prop-CoA+CO2+ATP↔Mema-CoA+ADP+Pi 5.94 2.97 0.09 5 2.88 0.27 0.6 0 56 73 8 57 65 76 0.41 
62 Mema-CoA↔Succ-CoA 1.65 0.82 0.27 0 0 0.65 0 0 57 0 0 31 0 0 0.41 
63 3-PG+NAD↔PHP+NADH 0.0756 0.0378 2.36 1.69 0 0.6 0.53 0 18 1 0 58 63 0 0.01 
64 PHP+Glutamate↔a-KG+3Pser 0.0715 0.0357 0.6 12 0 0.65 0.09 0 58 60 0 30 59 0 0.01 
65 3Pser→serine+Pi 0.0192 0 0.09 0 0 0 0 0 59 0 0 14 76 0 0.01 
66 Glutamate+NADP←NH4+a-KG+NADPH 0 0.316 12 0.62 0 1 0.65 0.42 60 5 0 74 30 64 -0.02 
67 NADH+Q+H->NAD+QH2 47.9 50 0.53 0.98 6.3 1.69 1.02 0 63 61 77 1 68 0 -0.30 
68 QH2+2Cyt-cox↔Q+2Cyt-cred+2H 513 500 1.02 0 0 0.98 6.3 6.3 68 0 0 61 77 77 1.72 
69 FADH2+Q↔FAD+QH2 23.1 20 0.11 0.98 0 0.99 1.02 0 67 61 0 35 68 0 0.84 
70 ATP↔ADP+2H+Pi 191 200 2.88 0 0 0.6 6.3 6.3 8 0 0 65 77 77 -1.80 
71 ATP+GDP↔ADP+GTP 23.1 25 2.88 0.11 0 0.6 0.99 0 8 32 0 65 66 0 -0.42 
72 NADPH+Q+H↔NAPD+QH2 50.5 50 0.42 0.98 6.3 0.62 1.02 0 64 61 77 5 68 0 0.14 
73 NADH+NADP↔NADPH+NAD 105 100 0.53 0.62 0 0.42 1.69 0 63 5 0 64 1 0 1.26 
74 2e+Q→QH2 8.33 0 0.2 0.2 0.98 0 0 0 81 81 61 68 0 0 1.04 
75 2Glyoxylate↔hydropyruvate 0 0 12.6 12.6 0 1.4 0 0 15 15 0 16 0 0 0 
76 Serine+NH4↔Pyruvate 0.00541 0.00271 4.89 0 0 3.85 0 0 14 0 0 25 0 0 0.00 
77 Acetoac+CoA+ATP↔Acetoac-CoA+ADP+Pi 0.544 0.272 0.85 0.1 2.88 0.18 0.6 3 52 26 8 48 65 76 0.03 
78 Glycine+NAD+H4F↔Methylene-H4F+NADH+ 
NH3+ CO2 
0.000431 0.000216 16.6 1.69 0 0.07 0.53 0 13 1 0 3 63 0 0.00 
79 Pyruvate-Out↔Pyruvate 5.65 0.01 10 0 0 10 0 0 78 0 0 25 0 0 0.00 
80 Succinate-Out↔Succinate 7.00 0.25 0.1 0 0 10 0 0 79 0 0 33 0 0 0.00 
Columns VF and VB are the forward and backward velocity (in millimolar/second) of the reactions respectively. Columns Ki=1,2,3 are the 
(Michalis-Menten-like) Km  (in millimolar) of the reactants. Columns K’j=1,2,3 are the (Michaelis-Menten-like) Km (in millimolar) of the 
products. Columns i1, i2, i3 contains the metabolite index for the reactants. Columns j1, j2, j3 contains the metabolite index for the products. 
Column s.s.f stands for steady state flux (in millimolar/second) 
 
Next we show a result from perturbing the steady 
state. We set the initial concentrations at the steady 
state value except for one. In this case, the 
formaldehyde concentration is set to twice it’s steady 
state value. We follow the predicted dynamics of the 
system and see how the concentrations relax back to 
their steady state value. In Fig. 2., we plot the predicted 
concentrations divided by their steady state values as a 
function of time. Each line represents a metabolite’s 
concentration in the plot and in this plot we have only 
labeled a few that show a large relative variation. We 
find the system is predicted to be robust, as it relaxes 
back to the same steady state eventually. Different 
metabolites also relax back to the steady state at 
different times. Such behaviors are consistent with in 
vivo experimental observations. 
 
Since formaldehyde is highly toxic to most 
organisms, it is of great interest to understand how the 
bacterium deals with such a toxic intermediate[55]. Our 
simulation predicts that the formaldehyde 
concentration is able to reach steady state 
concentration in the shortest time as compared to other 
metabolites (e.g. succinate not shown). This suggests 
that a mechanism is already in place in our kinetic 
model to deal with sudden large fluctuations in 
formaldehyde concentrations. Furthermore, perturbation 
in formaldehyde concentration is not predicted to 
 impact other pathways as much. Fig. 3 shows the 
corresponding predicted variations in the fluxes. Again, 
such dynamical behaviors are consistent with 
biological observations. 
 
 
Fig. 2  Response in concentration to a perturbation in the 
formaldehyde concentration at steady state values 
The concentration of formaldehyde was doubled at t=0 while the 
other concentration are at steady state values 
 
 
Fig. 3 Response in flux to a perturbation in the 
formaldehyde concentration at steady state values 
The concentration of formaldehyde was doubled at t=0 while the 
other concentration are at steady state values. The numbering of 
fluxes is in accordance with numbering of reactions as in Table 3 
 
 
3  Conclusions 
 
We have been developing a systematic methodology 
to perform the real time kinetic modeling of large 
metabolic networks based on incompletely kinetic 
parameter information. A successful major step is 
reported here: The validation of the modeling has been 
carried out using the central metabolism of M. 
extorquens AM1 under methanol growth. 
The critical issue we encountered in constructing 
such computational model is the large number of 
unknown parameters in the enzymatic rate equations. 
We use generic rate equations which can be written 
with a minimum set of parameters. Some kinetic 
parameters can be directly inferred from experimental 
values, and directly from those of concentrations and 
fluxes. The rest can be computed according to the 
procedure described in the present paper. 
We also demonstrate that the model is robust with 
respect to fluctuations in formaldehyde in Fig. 2 where 
formaldehyde concentration is doubled from its steady 
state value. In our case, equilibrium is reached by the 
mathematical model via an autonomous adjusting 
substrate intake and its biomass production according 
to the need for metabolites and energy. A full 
exploration of other situations, such as different 
substrates, gene knockouts, will be explored in 
following-up publications. 
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